2012 - In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi (original) (raw)

In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi

Wagner Alves DE Souza Júdice

PLoS ONE

View PDFchevron_right

1 In vitro and in vivo evaluation of anti-leishmanial and.pdf

Radheshyam Maurya

View PDFchevron_right

preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis?

Rodrigo Luiz O. R. Cunha

Environmental Toxicology and Pharmacology, 2020

View PDFchevron_right

Applied Life Science Synthetic and Natural Products Against Leishmaniasis: A Review

Praful Chaudhari

2012

View PDFchevron_right

Furazolidone is a selective in vitro candidate against Leishmania ( L. ) chagasi : an ultrastructural study

gustavo giron

Parasitology Research, 2010

View PDFchevron_right

In vitro and in vivo anti-Leishmania activity of polysubstituted synthetic chalcones

Yannick Estevez

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

A Novel Organotellurium Compound (RT01) as a New Antileishmanial Agent

Camila Lima

Korean Journal of Parasitology - KOREAN J PARASITOL, 2009

View PDFchevron_right

Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice

Rosane Silva

International Journal of Antimicrobial Agents, 2012

View PDFchevron_right

In Vivo Antileishmanial Efficacy of Miltefosine Against Leishmania ( Leishmania ) amazonensis

María Fernanda García Bustos

Journal of Parasitology, 2014

View PDFchevron_right

Leishmaniasis treatment—a challenge that remains: a review

Carla Rangel

Parasitology Research, 2008

View PDFchevron_right

Novel Compounds Active against Leishmania major

C. Selitrennikoff

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology

Naouel Eddaikra

BioMed research international, 2016

View PDFchevron_right

In Vivo Therapeutic Effects of Four Synthesized Antileishmanial Nanodrugs in the Treatment of Leishmaniasis

Ali Khamesipour

Iranian Journal of Clinical Infectious Diseases, 2018

View PDFchevron_right

Vitamins (A) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs

Ramesh Kandimalla

Scientific Reports

View PDFchevron_right

Effects of trans-stilbene and terphenyl compounds on different strains of Leishmania and on cytokines production from infected macrophages

Fabrizio Vitale

Experimental parasitology, 2018

View PDFchevron_right

Chemotherapy of Leishmaniasis: Past, Present and Future

Jyotsna Mishra, Anubha Saxena, Dr Sarman Singh

Current Medicinal Chemistry, 2007

View PDFchevron_right

Activity of the Novel Immunomodulatory Compound Tucaresol against Experimental Visceral Leishmaniasis

John Rhodes

Antimicrobial Agents and Chemotherapy, 2000

View PDFchevron_right

Treatment of Experimental Leishmaniasis with the Immunomodulators Imiquimod and S‐28463: Efficacy and Mode of Action

S. Buates

The Journal of Infectious Diseases, 1999

View PDFchevron_right

Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania ( Leishmania) amazonensis

Marcio Gomes

Veterinary Parasitology, 2006

View PDFchevron_right

Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum

Antonieta Rojas de Arias

Parasitology International, 2015

View PDFchevron_right

Targeting of Parasite‐Specific Immunoliposome‐Encapsulated Doxorubicin in the Treatment of Experimental Visceral Leishmaniasis

Dr Labanyamoy Kole

The Journal of Infectious Diseases, 2004

View PDFchevron_right

Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007)

Eduardo Gomez

The American journal of tropical medicine and hygiene, 2002

View PDFchevron_right

Enhancement in therapeutic efficacy of miltefosine in combination with synthetic Bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis

Preeti Vishwakarma

Experimental Parasitology, 2012

View PDFchevron_right

The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade

Whelton Miller

2021

View PDFchevron_right

Licochalcone a Exhibits Leishmanicidal Activity in vitro and in Experimental Model of Leishmania (Leishmania) Infantum

Renato L T Parreira

Frontiers in Veterinary Science

View PDFchevron_right

Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions

serina Giorgio

2008

View PDFchevron_right